The Pharma Data

NOVEMBER 11, 2020

He continued his education at Indiana University, where he completed a Master of Arts in botany in 1964, and a Doctor of Philosophy in organic chemistry in 1965. He accepted a faculty position at the University of Mississippi in 1978, rising to become the director of the school’s Research Institute of Pharmaceutical Sciences in 1986.

Organic Chemistry 52

Organic Chemistry Science Pharmacy Pharmaceuticals 52

Eye on FDA

JULY 7, 2020

In the now distant past, enforcement from this office, then called the Division of Drug Marketing, Advertising, and Communications (DDMAC) and later re-named OPDP, was robust, with the office issuing scores of letters a year (156 were issued in 1998). This item disappeared from the agenda, however, and no draft guidance was issued.

FDA 52

FDA Pharmaceutical Companies Doctors Regulations 52

Drug & Device Law

JULY 24, 2023

We’ve discussed recently how a federal statute intended to allow suits against international terrorists has been misapplied as allowing suits against pharmaceutical companies. Takeda Pharmaceuticals Co. , Takeda Pharmaceutical Co. , at *6 (plaintiff “has documents and formularies reaching back to only 2009”).

Testimonials 52

Testimonials Pharmacy FDA Doctors 52

Drug & Device Law

FEBRUARY 16, 2023

procedures that did not use spinal fixation devices” was “irrelevant in a suit against the product manufacturer because “it questioned the medical judgment of doctors”). Wyeth Pharmaceuticals, Inc. , Wyeth Pharmaceuticals, Inc. , Danek Medical, Inc. , 3d 154, 162 (4th Cir. Texas adopted the Third Restatement, and in Brockert v.

FDA 59

FDA Production FDA Approval Treatment 59

Drug & Device Law

JUNE 6, 2022

Further, “both doctors testified that they still prescribe [the drug] for patients with conditions similar to plaintiff’s condition.” 2009), reversed a plaintiff’s verdict for entry of judgment n.o.v. Bayer HealthCare Pharmaceuticals, Inc. , Wyeth Pharmaceuticals , 526 F.3d Schering Corp. , 2d 1140, 1148 (N.J.

Testimonials 59

Testimonials Production Pharmaceuticals Treatment 59

Drug & Device Law

MAY 30, 2022

The law presumes that licensed doctors know what they are doing. 1978), where a hypertensive patient was injured after being injected with the defendant’s drug – despite warnings that “expressly directed the doctor administering the drug to refrain from giving it to a patient with hypertension.” Wyeth Pharmaceuticals , 526 F.3d

Testimonials 59

Testimonials Doctors Production Laboratories 59

Drug & Device Law

DECEMBER 11, 2023

May 28, 2015)); here (discussing In re Yasmin & Yaz (Drospirenone) Marketing, Sales Practices & Products Liability Litigation , 2011 WL 2746086 (S.D. 2009 WL 1809990 (S.D. 2009)); here (discussing DeGidio v. 2009 WL 1867676 (N.D. Ohio June 29, 2009)); and here (discussing Joseph v. Ohio 2009)).

Production 102

Production Hospitals Pharmaceuticals Doctors 102